Preclinical activity of two paclitaxel nanoparticle formulations after IP administration in ovarian cancer xenografts
- Author
- Charlotte Carlier, Anne Hoorens (UGent) , Kaat De Clercq, Silvia Giordano, Lavinia Morosi, Enrico Davoli, Jo Van Dorpe (UGent) , Chris Vervaet (UGent) , Frank Vanhaecke (UGent) and Wim Ceelen (UGent)
- Organization
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8553083
- MLA
- Carlier, Charlotte, et al. “Preclinical Activity of Two Paclitaxel Nanoparticle Formulations after IP Administration in Ovarian Cancer Xenografts.” Regional Cancer Therapies, 13th International Symposium, Abstracts, 2018.
- APA
- Carlier, C., Hoorens, A., De Clercq, K., Giordano, S., Morosi, L., Davoli, E., … Ceelen, W. (2018). Preclinical activity of two paclitaxel nanoparticle formulations after IP administration in ovarian cancer xenografts. Regional Cancer Therapies, 13th International Symposium, Abstracts. Presented at the 13th International symposium on Regional Cancer Therapies (SSO 2018), Jacksonville, FL, USA.
- Chicago author-date
- Carlier, Charlotte, Anne Hoorens, Kaat De Clercq, Silvia Giordano, Lavinia Morosi, Enrico Davoli, Jo Van Dorpe, Chris Vervaet, Frank Vanhaecke, and Wim Ceelen. 2018. “Preclinical Activity of Two Paclitaxel Nanoparticle Formulations after IP Administration in Ovarian Cancer Xenografts.” In Regional Cancer Therapies, 13th International Symposium, Abstracts.
- Chicago author-date (all authors)
- Carlier, Charlotte, Anne Hoorens, Kaat De Clercq, Silvia Giordano, Lavinia Morosi, Enrico Davoli, Jo Van Dorpe, Chris Vervaet, Frank Vanhaecke, and Wim Ceelen. 2018. “Preclinical Activity of Two Paclitaxel Nanoparticle Formulations after IP Administration in Ovarian Cancer Xenografts.” In Regional Cancer Therapies, 13th International Symposium, Abstracts.
- Vancouver
- 1.Carlier C, Hoorens A, De Clercq K, Giordano S, Morosi L, Davoli E, et al. Preclinical activity of two paclitaxel nanoparticle formulations after IP administration in ovarian cancer xenografts. In: Regional Cancer Therapies, 13th International symposium, Abstracts. 2018.
- IEEE
- [1]C. Carlier et al., “Preclinical activity of two paclitaxel nanoparticle formulations after IP administration in ovarian cancer xenografts,” in Regional Cancer Therapies, 13th International symposium, Abstracts, Jacksonville, FL, USA, 2018.
@inproceedings{8553083, author = {{Carlier, Charlotte and Hoorens, Anne and De Clercq, Kaat and Giordano, Silvia and Morosi, Lavinia and Davoli, Enrico and Van Dorpe, Jo and Vervaet, Chris and Vanhaecke, Frank and Ceelen, Wim}}, booktitle = {{Regional Cancer Therapies, 13th International symposium, Abstracts}}, language = {{eng}}, location = {{Jacksonville, FL, USA}}, title = {{Preclinical activity of two paclitaxel nanoparticle formulations after IP administration in ovarian cancer xenografts}}, year = {{2018}}, }